How Eric Lefkofksy and Tempus are Revolutionizing Cancer Research
Eric Lefkofsky is a fascinating man. That statement can not be denied. He is known as one of Chicago’s greatest tech influencers and his ventures over the years have produced incredible success through a variety of verticals in the dot-com world. He is probably best known for co-founding Groupon with the goal of changing the way consumers engage with sellers of goods and services who are eager to reach those consumers.
Born in Michigan and a graduate of the University of Michigan as well as University of Michigan Law School, Eric Lefkofsky is known as a man that when he sees a problem, he is the first to begin to brainstorm on a solution. His latest venture, Tempus, was recently featured in Tech News Spy for the extraordinary and revolutionary goal they have set to lead the charge against cancer with data-driven research.
The overarching goal is to utilize molecular data gathering from Human Genome Sequencing combined with data gathering from actual patient research and combine the two into an easily accessible format that will help doctors determine the best treatment for individual cancer patients and more information click here.
However, although Tempus has the funding to create the platform, access to the data itself was their first hurdle. The second hurdle Tempus faced was gathering the information about patient data that was often stored in the physician’s notes, which were not submitted to any type of streamlined database. However, Tempus created another software platform that could analyze and pull data from those notes and again help move along the process of data-driven cancer care.
Molecular data is genetic information that is collected by a process called human genome sequencing. This process used to be very expensive, upwards of $100 million, but has now dropped to several thousand and is expected to drop even lower thanks to the commitment of companies like Tempus to make the process affordable. Human Genome Sequencing reveals clues inside genes that can make it easier to fight cancer and other diseases. By pairing patient information and data gathered from physicians and combining that with molecular information that is collected by human genome sequencing, the hope is to make connections that will unveil new ways to fight cancer and learn more about Eric.
More Visit: http://www.lightbank.com/team/eric-lefkofsky